Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition-Reference-Cited by-同舟云学术

Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition

Published:2024-03 Issue: Volume: Page:116166
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Marin Jose J.G.^ORCID,Cives-Losada Candela,Macias Rocio I.R.,Romero Marta R.,Marijuan Rebeca P.,Hortelano-Hernandez Nazaret,Delgado-Calvo Kevin,Villar Carmen,Gonzalez-Santiago Jesus M.,Monte Maria J.,Asensio Maitane

Funder

Fundación Científica de la Asociación Española Contra el Cáncer

Junta de Castilla y Leon

University of Salamanca

Fundació la Marató de TV3

Asociación Española Para el Estudio del Hígado

Espana Ministerio de Ciencia e Innovacion

Instituto de Salud Carlos III

Publisher

Elsevier BV

Reference272 articles.

1. SLC family transporters;Liu;Adv Exp Med Biol,2019

2. Molecular bases of drug resistance in Hepatocellular Carcinoma;Marin;Cancers,2020

3. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties;Hagenbuch;Pflugers Arch,2004

4. The superfamily of organic anion transporting polypeptides;Hagenbuch;Biochim Biophys Acta,2003

5. Organic anion transporting polypeptides of the OATP/SLCO superfamily: identification of new members in nonmammalian species, comparative modeling and a potential transport mode;Meier-Abt;J Membr Biol,2005

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An introduction to the special issue “Sam Enna legacy of excellence”;Biochemical Pharmacology;2024-08